{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:16:59Z","timestamp":1774567019389,"version":"3.50.1"},"reference-count":48,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,12,1]]},"abstract":"<jats:title>This Technical Report was retired August 2010.<\/jats:title>\n               <jats:p>In 1998, the Food and Drug Administration (FDA) approved the licensure of tobramycin solution for inhalation (TOBI). Although a number of additional antibiotics, including other aminoglycosides, \u03b2-lactams, antibiotics in the polymyxin class, and vancomycin, have been administered as aerosols for many years, none are approved by the FDA for administration by inhalation.<\/jats:p>\n               <jats:p>TOBI was approved by the FDA for the maintenance therapy of patients 6 years or older with cystic fibrosis (CF) who have between 25% and 75% of predicted forced expiratory volume in 1 second (FEV1), are colonized with Pseudomonas aeruginosa, and are able to comply with the prescribed medical regimen. TOBI was not approved for the therapy of acute pulmonary exacerbations in patients with CF nor was it approved for use in patients without CF. Currently, no other antibiotics are approved for administration by inhalation to patients with or without CF.<\/jats:p>\n               <jats:p>The purpose of this statement is to briefly summarize the data that supported approval for licensure of TOBI and to provide recommendations for its safe use. The pharmacokinetics of inhaled aminoglycosides and problems associated with aerosolized antibiotic treatment, including environmental contamination, selection of resistant microbes, and airway exposure to excipients in intravenous formulations, will be discussed.<\/jats:p>","DOI":"10.1542\/peds.106.6.e89","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:50:41Z","timestamp":1092441041000},"page":"e89-e89","source":"Crossref","is-referenced-by-count":38,"title":["Technical Report: Precautions Regarding the Use of  Aerosolized Antibiotics"],"prefix":"10.1542","volume":"106","author":[{"given":"Charles G.","family":"Prober","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Walson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Committee on Infectious Diseases and Committee on Drugs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2000,12,1]]},"reference":[{"key":"2023081713454294600_B1","first-page":"137","article-title":"Safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis. The results of two phase III placebo controlled clinical trials.","volume":"24","author":"Ramsey","year":"1997","journal-title":"Pediatr Pulmonol."},{"key":"2023081713454294600_B2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med."},{"key":"2023081713454294600_B3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(81)90588-2","article-title":"Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.","volume":"2","author":"Hodson","year":"1981","journal-title":"Lancet."},{"key":"2023081713454294600_B4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0007-0971(87)90184-7","article-title":"A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis.","volume":"81","author":"Carswell","year":"1987","journal-title":"Br J Dis Chest."},{"key":"2023081713454294600_B5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0007-0971(87)90161-6","article-title":"Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected withPseudomonas aeruginosa.","volume":"81","author":"Stead","year":"1987","journal-title":"Br J Dis Chest."},{"key":"2023081713454294600_B6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.1950060207","article-title":"Long-term tobramycin aerosol therapy in cystic fibrosis.","volume":"6","author":"Steinkamp","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"2023081713454294600_B7","first-page":"43","article-title":"Nebulized gentamicin in children and adolescents with cystic fibrosis.","volume":"20","author":"Kun","year":"1984","journal-title":"Aust Pediatr J."},{"key":"2023081713454294600_B8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.1950070110","article-title":"Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized withPseudomonas aeruginosa.","volume":"7","author":"MacLusky","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"2023081713454294600_B9","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199306173282403","article-title":"Efficacy of aerosolized tobramycin in patients with cystic fibrosis.","volume":"328","author":"Ramsey","year":"1993","journal-title":"N Engl J Med."},{"key":"2023081713454294600_B10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-198305000-00007","article-title":"Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis.","volume":"2","author":"Stephens","year":"1983","journal-title":"Pediatr Infect Dis."},{"key":"2023081713454294600_B11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0022-3476(87)80130-0","article-title":"Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.","volume":"111","author":"Schaad","year":"1987","journal-title":"J Pediatr."},{"key":"2023081713454294600_B12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3476(82)80726-9","article-title":"Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin.","volume":"101","author":"Nolan","year":"1982","journal-title":"J Pediatr."},{"key":"2023081713454294600_B13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(85)92222-6","article-title":"Nebulized colimycin for early pseudomonas colonisation in cystic fibrosis.","volume":"1","author":"Littlewood","year":"1985","journal-title":"Lancet."},{"key":"2023081713454294600_B14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jac\/19.6.831","article-title":"Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.","volume":"19","author":"Jensen","year":"1987","journal-title":"J Antimicrob Chemother."},{"key":"2023081713454294600_B15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0140-6736(91)91446-2","article-title":"Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.","volume":"338","author":"Valerius","year":"1991","journal-title":"Lancet."},{"key":"2023081713454294600_B16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O","article-title":"Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.","volume":"23","author":"Frederiksen","year":"1997","journal-title":"Pediatr Pulmonol."},{"key":"2023081713454294600_B17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1651-2227.1993.tb12668.x","article-title":"Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.","volume":"82","author":"Vazquez","year":"1993","journal-title":"Acta Paediatr."},{"key":"2023081713454294600_B18","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1164\/ajrccm.155.6.9196111","article-title":"Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis.","volume":"155","author":"Lin","year":"1997","journal-title":"Am J Respir Crit Care Med."},{"key":"2023081713454294600_B19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00003246-199801000-00013","article-title":"Aerosolized antibiotics in mechanically ventilated patients: delivery and response.","volume":"26","author":"Palmer","year":"1998","journal-title":"Crit Care Med."},{"key":"2023081713454294600_B20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.2.5551.543","article-title":"Gentamicin and colistin in chronic purulent bronchial infections.","volume":"2","author":"Pines","year":"1967","journal-title":"Br Med J."},{"key":"2023081713454294600_B21","first-page":"1233","article-title":"Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus (in Japanese).","volume":"33","author":"Shirai","year":"1995","journal-title":"Nippon Kyobu Shikkan Gakkai Zasshi."},{"key":"2023081713454294600_B22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1701007","article-title":"Inhaled vancomycin-induced allergic reaction in decontamination of respiratory tracts for allogeneic bone marrow transplantation.","volume":"20","author":"Kahata","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"2023081713454294600_B23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJM197509042931003","article-title":"Aerosol polymyxin and pneumonia in seriously ill patients.","volume":"293","author":"Feeley","year":"1975","journal-title":"N Engl J Med."},{"key":"2023081713454294600_B24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1099-0496(199704)23:4<249::AID-PPUL2>3.0.CO;2-H","article-title":"Effect of nebulizer type and antibiotic concentration on device performance.","volume":"23","author":"Weber","year":"1997","journal-title":"Pediatr Pulmonol."},{"key":"2023081713454294600_B25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00063198-199711000-00005","article-title":"Choosing a nebulizer for cystic fibrosis applications.","volume":"3","author":"Geller","year":"1997","journal-title":"Curr Opin Pulm Med."},{"key":"2023081713454294600_B26","doi-asserted-by":"crossref","first-page":"152S","DOI":"10.1378\/chest.88.2_Supplement.152S","article-title":"Aerosol deposition considerations in inhalation therapy.","volume":"88","author":"Newman","year":"1985","journal-title":"Chest."},{"key":"2023081713454294600_B27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1378\/chest.111.5.1206","article-title":"The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.","volume":"111","author":"Coates","year":"1997","journal-title":"Chest."},{"key":"2023081713454294600_B28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/thx.38.10.755","article-title":"Factors influencing the size distribution of aerosols from jet nebulizers.","volume":"38","author":"Clay","year":"1983","journal-title":"Thorax."},{"key":"2023081713454294600_B29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.43.12.987","article-title":"Influence of breathing pattern on lung deposition and bronchodilator response to nebulized salbutamol in patients with stable asthma.","volume":"43","author":"Zainudin","year":"1988","journal-title":"Thorax."},{"key":"2023081713454294600_B30","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1164\/ajrccm\/136.6.1445","article-title":"Quantitative deposition of aerosolized gentamicin in cystic fibrosis.","volume":"136","author":"Iliwite","year":"1987","journal-title":"Am Rev Respir Dis."},{"key":"2023081713454294600_B31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.93.03060715","article-title":"Pharmacokinetics of antibiotics in the lungs.","volume":"3","author":"Valcke","year":"1990","journal-title":"Eur Respir J."},{"key":"2023081713454294600_B32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1378\/chest.83.6.904","article-title":"Bronchial tree penetration of antibiotics.","volume":"83","author":"Smith","year":"1983","journal-title":"Chest."},{"key":"2023081713454294600_B33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/ajrccm\/147.5.1279","article-title":"Lung distribution and pharmacokinetics of aerosolized tobramycin.","volume":"147","author":"Le Conte","year":"1993","journal-title":"Am Rev Respir Dis."},{"key":"2023081713454294600_B34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/AAC.41.1.184","article-title":"Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis.","volume":"41","author":"Touw","year":"1997","journal-title":"Antimicrob Agents Chemother."},{"key":"2023081713454294600_B35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.111.4.955","article-title":"A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.","volume":"111","author":"Eisenberg","year":"1997","journal-title":"Chest."},{"key":"2023081713454294600_B36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365528809090221","article-title":"Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.","volume":"143","author":"Gappa","year":"1988","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2023081713454294600_B37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ppul.1950070413","article-title":"Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis.","volume":"7","author":"Smith","year":"1989","journal-title":"Pediatr Pulmonol."},{"key":"2023081713454294600_B38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000196489","article-title":"Aerosol administration of antibiotics.","volume":"62","author":"Smith","year":"1995","journal-title":"Respiration."},{"key":"2023081713454294600_B39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/BF01957914","article-title":"Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.","volume":"155","author":"Nikolaizik","year":"1996","journal-title":"Eur J Pediatr."},{"key":"2023081713454294600_B40","first-page":"274","article-title":"Acute respiratory failure due to gentamicin aerosolization.","volume":"53","author":"Melani","year":"1998","journal-title":"Monaldi Arch Chest Dis."},{"key":"2023081713454294600_B41","first-page":"53","article-title":"Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.","volume":"8","author":"Burns","year":"1993","journal-title":"Adv Pediatr Infect Dis."},{"key":"2023081713454294600_B42","first-page":"335","article-title":"Pseudomonas aeruginosa and cystic fibrosis: antibiotic therapy and the science behind the magic.","volume":"8","author":"MacDonald","year":"1997","journal-title":"Can J Infect Dis"},{"key":"2023081713454294600_B43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/clinids\/23.3.532","article-title":"Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.","volume":"23","author":"Saiman","year":"1996","journal-title":"Clin Infect Dis."},{"key":"2023081713454294600_B44","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis."},{"key":"2023081713454294600_B45"},{"key":"2023081713454294600_B46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3476(98)70497-4","article-title":"Home nebulizer use among patients with cystic fibrosis.","volume":"132","author":"Rosenfeld","year":"1998","journal-title":"J Pediatr."},{"key":"2023081713454294600_B47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0195-6701(97)90195-X","article-title":"Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.","volume":"36","author":"Jakobsson","year":"1997","journal-title":"J Hosp Infect."},{"key":"2023081713454294600_B48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0002-9343(84)90520-5","article-title":"Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols.","volume":"77","author":"Craven","year":"1984","journal-title":"Am J Med."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/6\/e89\/1519586\/e89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/6\/e89\/1519586\/e89.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:46:58Z","timestamp":1692280018000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/106\/6\/e89\/63208\/Technical-Report-Precautions-Regarding-the-Use-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,12,1]]},"published-print":{"date-parts":[[2000,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.106.6.e89","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12,1]]}}}